PRSS8
PRSS8
PRSS8, also known as Prostasin, is a serine protease enzyme encoded by the PRSS8 gene in humans. This enzyme is involved in various physiological processes, including sodium balance, epithelial sodium channel (ENaC) regulation, and skin barrier function.
Structure[edit | edit source]
PRSS8 is a glycosylphosphatidylinositol (GPI)-anchored serine protease. The enzyme is synthesized as a zymogen and requires proteolytic cleavage to become active. The active form of PRSS8 consists of a catalytic triad typical of serine proteases, which includes histidine, aspartate, and serine residues.
Function[edit | edit source]
PRSS8 plays a crucial role in the regulation of the epithelial sodium channel (ENaC), which is essential for sodium homeostasis and blood pressure regulation. By cleaving and activating ENaC, PRSS8 facilitates sodium reabsorption in the kidney and other epithelial tissues. This process is vital for maintaining fluid balance and blood pressure.
In addition to its role in sodium balance, PRSS8 is involved in skin barrier function. It contributes to the processing of proteins that are essential for the formation of the stratum corneum, the outermost layer of the skin. This function is critical for protecting the body against environmental insults and preventing water loss.
Clinical Significance[edit | edit source]
Mutations or dysregulation of PRSS8 have been implicated in several medical conditions. For instance, altered PRSS8 activity is associated with hypertension due to its role in sodium reabsorption. Furthermore, PRSS8 has been studied in the context of skin disorders, such as ichthyosis, where its role in skin barrier function is compromised.
Research has also explored the potential of PRSS8 as a biomarker for certain cancers, given its expression in various epithelial tissues and its involvement in cellular processes that can be dysregulated in cancer.
Research and Therapeutic Potential[edit | edit source]
Ongoing research is investigating the therapeutic potential of targeting PRSS8 in diseases related to its function. Modulating PRSS8 activity could offer new avenues for treating hypertension and skin disorders. Additionally, understanding its role in cancer could lead to novel diagnostic and therapeutic strategies.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
